and should be tested in prospective clinical trials.
Ironically, with the wide use of spatially accurate radiation techniques, such as intensity-modulated radiotherapy and/or image-guided radiotherapy, interobserver variabilities in the contouring of clinical target volumes (CTVs) can be a major factor contributing to radiation inaccuracy, which can influence clinical outcomes. 5 Therefore, experts have developed consensus guidelines to help with CTV delineation in challenging tumors such as head and neck cancers, including nasopharyngeal carcinoma. 6 These guidelines are an important educational endeavor to reduce undesirable variations in clinical practice. In addition to these guidelines, clinical trials are needed to optimize the CTVs for certain tumor sites and stages. Therefore, our group is conducting 2 randomized phase-3 trials to determine whether we can safely spare the lower neck nodes (NCT02642107) in the clinically uninvolved neck and the medial retropharyngeal nodes (NCT03346109) in patients with nasopharyngeal carcinoma. If successful, these studies will help to reduce toxic effects in these patients. In summary, we believe that radiation approaches and trials need to be revolutionized to avoid being marginalized in the precision-medicine era.
